The Human Cancer PrimaCell™ 12: Ovarian Tumor Cells is for rapid (7-10 days) isolation and growth of human ovarian tumor cells from human ovarian tumor tissues. This system features an optimal condition of tissue dissociation system, Cancer OptiTDS™ that yields 6-8 times of single cells more than most of the tissue dissociation protocols published in the literature. In addition, this system ensures a high viability of the target cells with improved gradient contained in the culture medium.

Human Cancer PrimaCell™ 12 System (Cat No. 2-96035):
Human Cancer PrimaCell™ 12: Ovarian Tumor Cells Protocols
Human Cancer Tissue Preparation Buffer 12: Ovarian tumor Cells
Human Cancer OptiTDS™ 12: Tissue Dissociation System
Human Cancer PrimaCell™ 12: Ovarian Tumor Cells Growth Medium
Human Cancer PrimaCell™ 12: Ovarian Tumor Cells Growth Supplements with Serum (for 500 ml medium)

References:

[1] Kurbacher CM, Korn C, Dexel S, Schween U, Kurbacher JA, Reichelt R, Arenz PN. Isolation and culture of ovarian cancer cells and cell lines. Methods Mol Biol. 2011;731:161-80.
[2] Scarberry KE, Dickerson EB, Zhang ZJ, Benigno BB, McDonald JF. Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles. Nanomedicine. 2010 Jun;6(3):399-408. Epub 2009 Dec 5.
[3] Shepherd TG, Thériault BL, Campbell EJ, Nachtigal MW. Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc. 2006;1(6):2643-9.